Effects of the probiotic formulation SLAB51 in <i>in vitro</i> and <i>in vivo</i> Parkinson’s disease models
Vanessa Castelli, Michele d’Angelo, Francesca Lombardi, Margherita Alfonsetti, Andrea Antonosante, Mariano Catanesi, Elisabetta Benedetti, Paola Palumbo, Maria Grazia Cifone, Antonio Giordano, Giovambattista Desideri, Annamaria Cimini
Abstract
models of PD. The results suggest that SLAB51 can be a promising candidate for the prevention or as coadjuvant treatment of PD.
Topics & Concepts
Parkinson's diseaseIn vivoProbioticIn vitroDiseaseChemistryPharmacologyMedicineBiologyBiotechnologyInternal medicineBiochemistryBacteriaGeneticsParkinson's Disease Mechanisms and TreatmentsGABA and Rice ResearchChild Nutrition and Feeding Issues